Rosen Law Firm

Company

Last mentioned: Mar 21, 2026

Timeline

  1. Potential Settlement

    Typical timeframe for securities class actions to reach settlement or dismissal phases.

  2. Formal Complaint Filing

    Anticipated filing of detailed class action complaints if investigations yield actionable evidence.

  3. Lead Plaintiff Deadline

    Expected 60-day window for investors to move the court to serve as lead plaintiff.

  4. Lead Plaintiff Deadline

    The final date for investors to petition the court to lead the litigation against Enphase.

  5. Lead Plaintiff Deadline

    Final date for investors to move the court to serve as lead plaintiff in the action.

  6. Lead Plaintiff Deadline

    The final date for investors to petition the court to lead the class action lawsuit.

  7. ENPH Deadline

    Final day for Enphase Energy investors to move for lead plaintiff status.

  8. Lead Plaintiff Deadline

    Final date for investors to petition the court to serve as lead plaintiff in the consolidated action.

  9. PMI Deadline

    Final day for Picard Medical investors to move for lead plaintiff status.

  10. PSFE Deadline

    Final day for Paysafe investors to move for lead plaintiff status.

  11. Follow-up Counsel Alert

    Rosen Law Firm issues a second alert emphasizing its role as recognized counsel.

  12. Investigation Announced

    Rosen Law Firm officially launches investigation into potential securities fraud at SMCI.

  13. Rosen Law Firm Alert

    First major solicitation for Barclays investors to join class action litigation.

  14. Investigation Launch

    Rosen Law Firm issues public notices regarding probes into Barclays and Vital Farms.

  15. SEC Filing Activity

    Barclays submits multiple regulatory filings to the SEC.

  16. Institutional Sell-off

    Victory Capital Management Inc. reduces its holdings in Super Micro Computer shares.

  17. Litigation Expansion

    Additional filings and reminders are issued to shareholders by Pomerantz.

  18. Pomerantz Commencement

    Pomerantz LLP officially files class action litigation against the company.

  19. Legal Notices Issued

    Faruqi & Faruqi, LLP issues formal reminders for class action deadlines.

  20. Paysafe Earnings

    Paysafe reports mixed Q4 2025 results and issues FY26 outlook.

Stories mentioning Rosen Law Firm 16

regulation Neutral

Rosen Law Firm Targets Barclays and Vital Farms in Dual Securities Probes

Rosen Law Firm has initiated separate investigations into Barclays PLC and Vital Farms, Inc. for potential violations of federal securities laws. These probes signal a heightened period of litigation risk for both the global banking giant and the ethical food producer as the firm seeks lead plaintiffs for potential class action suits.

2 sources
regulation Neutral

Rosen Law Firm Launches Securities Probes into Barclays and Vital Farms

Rosen Law Firm has initiated dual investigations into potential securities law violations by global banking giant Barclays PLC and ethical food producer Vital Farms, Inc. These probes signal a heightened period of scrutiny for public companies regarding disclosure transparency and fiduciary duties.

2 sources
regulation Neutral

Enphase Energy Faces Securities Class Action Over Alleged Misleading Disclosures

Enphase Energy, Inc. is facing a significant securities class action lawsuit alleging that the company issued materially false or misleading statements during a critical growth period in 2025. The Rosen Law Firm has set an April 20, 2026, deadline for investors who suffered losses between April and October 2025 to seek lead plaintiff status.

2 sources
pharma Neutral

Corcept Therapeutics Faces Securities Fraud Lawsuit Amid Korlym Patent Battle

Rosen Law Firm has filed a class action lawsuit against Corcept Therapeutics (NASDAQ: CORT), alleging securities fraud during a period of intense patent litigation over its flagship drug, Korlym. The lawsuit covers investors who purchased shares between October 2024 and December 2025, following significant volatility linked to generic competition threats.

10 sources
corporate-law Neutral

Corcept Therapeutics Faces Securities Fraud Suit Over Disclosure Failures

Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.

10 sources
markets Neutral

Rosen Law Firm Targets PayPal in Class Action Following SEC Disclosures

The Rosen Law Firm has initiated a class action investigation into PayPal Holdings, Inc. (PYPL), urging investors to secure legal counsel following recent financial disclosures. The move comes after a series of SEC filings in early February 2026 revealed significant shifts in operations and executive leadership.

3 sources
corporate-law Neutral

Rosen Law Firm Targets PayPal in Securities Class Action Over Growth Disclosures

The Rosen Law Firm has initiated a securities class action investigation against PayPal Holdings, Inc., following a significant stock drop linked to the company's February 2026 financial disclosures. The firm is urging affected investors to secure legal counsel before the upcoming lead plaintiff deadline to address allegations of materially false or misleading business statements.

3 sources